Giacobbe P
Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
ArticleKetamine
Real-World Therapeutic Use of Ketamine in Clinical and Non-Clinical Settings: A Cross-Sectional Survey.
PreprintKetamine
Chronic sensing during subcallosal cingulate deep brain stimulation captures ketamine-associated changes in major depressive disorder
ArticlePsilocybin
Microdosing psychedelics: What, why, when, and how often? Insights from an international survey of people who use psychedelics.
ArticleKetamine
Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review.
ArticlePsilocybin
Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis.
ArticleMDMA
Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase).
ArticleKetamine
Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practicee.
ArticleKetamine
IN Esketamine and IV Ketamine: Results of a multi-site observational study assessing the effectiveness and tolerability of two novel therapies for treatment-resistant depression.
ArticlePsilocybin